January 5, 2021
Stanford single-dose nanoparticle vaccine for COVID-19
Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.
By Taylor Kubota
Related Topics
Dig Deeper
Related stories
News Feature
VIA Stanford
A newly published protein structure helps explain how some anti-cancer immunotherapy treatments work
March 12, 2024
News Feature
November 14, 2023
·
5 min read
News Feature
Stanford School of Humanities and Sciences
Stanford-SLAC study shows how modifying enzymes’ electric fields boosts their speed
October 25, 2023
News Feature
VIA Stanford
A newly published protein structure helps explain how some anti-cancer immunotherapy treatments work
March 12, 2024
News Feature
November 14, 2023
·
5 min read
News Feature
Stanford School of Humanities and Sciences
Stanford-SLAC study shows how modifying enzymes’ electric fields boosts their speed
October 25, 2023
News Feature
October 24, 2023
·
3 min read
News Feature
October 11, 2023
·
3 min read